Vaccine News and Research

Latest Vaccine News and Research

Bill and Melinda Gates Foundation grants $1.5million to Liverpool University for bacterial study

A University of Liverpool-led consortium has received $1.5million from the Bill & Melinda Gates Foundation to study a bacterium that causes serious disease and epidemics in sub-Saharan Africa.

14 Jan 2011

Personal genetic tests have promising effects on consumers

New findings from a landmark research study led by Scripps Health and the Scripps Translational Science Institute (STSI) reveal that personal genetic tests have some promising effects on consumers who choose to undergo the screenings. STSI is an initiative of Scripps Health in collaboration with The Scripps Research Institute.

13 Jan 2011

Antibiotic treatment may be sufficient to overcome River Blindness

The team found that a bacterium inside the worm acts as a 'disguise' for the parasite, resulting in the immune system reacting to it in an ineffective way. The bacteria protect the worm from the body's natural defences, but once the bacteria are removed with antibiotics, the immune system responds appropriately, releasing cells, called eosinophils, that kill the worm.

13 Jan 2011

New discovery has brought dream of transforming measles virus against cancer

When most people in the developed world think of measles, what comes to mind is only a dim memory of a vaccination at a pediatrician's office. But while childhood vaccination has virtually eliminated measles from North America and much of Europe, researchers remain interested in the virus.

13 Jan 2011

Offensive protein generated by HPV handicaps defensive protein made by the human body

An international team of researchers is reporting that it has uncovered new information about human papillomavirus that one day may aid in the development of drugs to eliminate the cervical-cancer-causing infection.

12 Jan 2011

PLoS Neglected Tropical Diseases features Inovio’s Chikungunya DNA vaccine

Inovio Pharmaceuticals, Inc., a leader in the development of novel therapeutic and preventive vaccines against cancers and infectious diseases, announced today the publication of a scientific paper highlighting positive results from Inovio's multi-antigen Chikungunya virus (CHIKV) DNA vaccine in PLoS Neglected Tropical Diseases.

12 Jan 2011

56% of respondents have still not received flu shots

As we enter peak flu season, flu activity is steadily increasing in the United States, with eight states now reporting widespread outbreaks of influenza cases according to the most recent Centers for Disease Control and Prevention (CDC) report.

12 Jan 2011

Antibodies produced by people who recovered from H1N1 offer clues for universal flu vaccine

The antibodies produced by individuals who fought off H1N1 (swine flu) infection last year may bring researchers one step closer to their quest to develop a "universal" flu vaccine, U.S. researchers said Monday, HealthDay News/Bloomberg Businessweek reports.

12 Jan 2011

NIDA awards Scripps Research, University of Pennsylvania $8.2M grant to develop tobacco addiction treatment

The Scripps Research Institute and the University of Pennsylvania School of Medicine have been awarded approximately $8.2 million over five years to develop novel compounds that could eventually become drug candidates for the treatment of tobacco addiction. Of the funds awarded, $5.7 million will go to Scripps Research, and $2.5 million to the University of Pennsylvania.

12 Jan 2011

'MMR doctor' planned scheme to make millions from his health scare

Andrew Wakefield, the disgraced doctor who claimed a link between MMR and autism, planned secret businesses intended to make huge sums of money, in Britain and America, from his now-discredited allegations.

12 Jan 2011

Herpes zoster vaccine reduces risk of developing shingles by 55%

Receiving the herpes zoster vaccine was associated with a 55 percent reduced risk of developing shingles, according to a Kaiser Permanente study of 300,000 people that appears in the current issue of the Journal of the American Medical Association.

12 Jan 2011

SciClone initiates phase 2b study of SCV-O7 for oral mucositis

SciClone Pharmaceuticals, Inc. (NASDAQ: SCLN) today announced the enrollment of the first patient in the company's phase 2b clinical trial of SCV-07 for the prevention of oral mucositis (OM) -- a painful, debilitating, and costly toxicity caused by chemoradiotherapy regimens used to treat head and neck cancer.

11 Jan 2011

Medical aid workers should take pre-travel precautions to prevent disease transmission

Guidance about pre-travel precautions and preventive measures are highlighted in the December 1, 2010 issue of Clinical Infectious Diseases, written by clinicians and researchers at the Uniformed Services University of the Health Sciences and their partners from the University of Texas Health Sciences Center, Naval Medical Research Center and others.

11 Jan 2011

Vaccine Safety Conference affirms urgent need for methodologically sound vaccine science

An international meeting was held in Montego Bay, Jamaica Jan. 3-7, 2011 to discuss current vaccine science and policy safety concerns. Delegates from around the world included senior scientists and physicians, editors of scientific journals, experts in vaccine regulation, social science and health policy, consumer child health advocates, legal experts and members of the media.

11 Jan 2011

Scientists create particles that resemble RBC, pave way for development of synthetic blood

A team of scientists has created particles that closely mirror some of the key properties of red blood cells, potentially helping pave the way for the development of synthetic blood.

11 Jan 2011

PakSense launches new class of temperature monitoring device

PakSense, an innovator in sensory solutions for packaging, announced today the launch of the PakSense BIOmed Label product line for use in clinical trials, pharmaceuticals, biologics, vaccines and other healthcare-related material transport.

11 Jan 2011

Less than 7% of U.S. seniors get shingles vaccination

Although a vaccine to prevent shingles has been available since 2006, less than 7 percent of U.S. seniors — the demographic most frequently affected by the disease — chose to receive the vaccination as of 2008, finds a new study from the Centers for Disease Control and Prevention (CDC).

11 Jan 2011

Pro-Pharmaceuticals to begin DAVANAT Phase III development program following FDA approval

Pro-Pharmaceuticals, the leading developer of therapeutics that target Galectin receptors to treat cancer and fibrosis, today announced that on December 17, 2010, Company representatives met with officials from the U.S. Food & Drug Administration to present its Phase III clinical development program for DAVANAT.

11 Jan 2011

Aid groups, U.N., U.S. discuss response to Haiti's earthquake as year anniversary approaches

On Friday, the Office of the U.N. Special Envoy to Haiti said that 63.6 percent of the aid international donors "pledged to Haiti in 2010 after a devastating earthquake nearly one year ago" has been disbursed, Deutsche Presse-Agentur/M&C reports (1/7).

11 Jan 2011

PPD announces joint venture with TBL to develop novel biotherapeutics

PPD, today announced it has established a joint venture with Taijitu Biologics Limited in the area of the discovery of novel biotherapeutics. The joint venture, named BioDuro Biologics, expands PPD's capability to deliver unique, highly differentiated drug discovery services for biopharmaceutical companies across the globe.

10 Jan 2011

Vaccine News and Research

Latest Vaccine News and Research

Bill and Melinda Gates Foundation grants $1.5million to Liverpool University for bacterial study

Personal genetic tests have promising effects on consumers

Antibiotic treatment may be sufficient to overcome River Blindness

New discovery has brought dream of transforming measles virus against cancer

Offensive protein generated by HPV handicaps defensive protein made by the human body

PLoS Neglected Tropical Diseases features Inovio’s Chikungunya DNA vaccine

56% of respondents have still not received flu shots

Antibodies produced by people who recovered from H1N1 offer clues for universal flu vaccine

NIDA awards Scripps Research, University of Pennsylvania $8.2M grant to develop tobacco addiction treatment

'MMR doctor' planned scheme to make millions from his health scare

Herpes zoster vaccine reduces risk of developing shingles by 55%

SciClone initiates phase 2b study of SCV-O7 for oral mucositis

Medical aid workers should take pre-travel precautions to prevent disease transmission

Vaccine Safety Conference affirms urgent need for methodologically sound vaccine science

Scientists create particles that resemble RBC, pave way for development of synthetic blood

PakSense launches new class of temperature monitoring device

Less than 7% of U.S. seniors get shingles vaccination

Pro-Pharmaceuticals to begin DAVANAT Phase III development program following FDA approval

Aid groups, U.N., U.S. discuss response to Haiti's earthquake as year anniversary approaches

PPD announces joint venture with TBL to develop novel biotherapeutics

Event guide: 3rd mRNA Process Development & Manufacturing Europe eBook

Synthetic Biology and the Pursuit of Living Diagnostics

Modular, Scalable, Intelligent: How n6 Is Rethinking NGS Library Prep

Shaping the future of lab automation through AI and robotics

Vaccine News and Research

Latest Vaccine News and Research

Event guide: 3rd mRNA Process Development & Manufacturing Europe eBook

Synthetic Biology and the Pursuit of Living Diagnostics

Modular, Scalable, Intelligent: How n6 Is Rethinking NGS Library Prep

Shaping the future of lab automation through AI and robotics

Newsletters you may be interested in